Natural product inspired N‐terminal Hsp90 inhibitors: from bench to bedside?

A Khandelwal, VM Crowley… - Medicinal research …, 2016 - Wiley Online Library
The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation
of nascent polypeptides and the rematuration of denatured proteins. Proteins dependent …

[HTML][HTML] Natural product inhibitors of Hsp90: potential leads for drug discovery

MW Amolins, BSJ Blagg - Mini reviews in medicinal chemistry, 2009 - ncbi.nlm.nih.gov
Heat shock protein 90 has emerged as a promising target for the treatment of cancer and
neurodegenerative diseases. This review summarizes recent advancements towards the …

Recent advances in the discovery of novel HSP90 inhibitors: an update from 2014

Y Xiao, Y Liu - Current Drug Targets, 2020 - ingentaconnect.com
HSP90 is a member of the family of heat shock proteins responsible for folding proteins into
mature conformations and thus maintaining their biological function in cells. Since it is …

The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition

SJ Mishra, W Liu, K Beebe, M Banerjee… - Journal of medicinal …, 2021 - ACS Publications
The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for
the folding of select proteins, many of which are directly associated with cancer progression …

[HTML][HTML] High-throughput screen of natural product libraries for hsp90 inhibitors

J Davenport, M Balch, L Galam, A Girgis, J Hall… - Biology, 2014 - mdpi.com
Hsp90 has become the target of intensive investigation, as inhibition of its function has the
ability to simultaneously incapacitate proteins that function in pathways that represent the six …

Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy

JR Porter, CC Fritz, KM Depew - Current opinion in chemical biology, 2010 - Elsevier
The Hsp90 chaperone is a master regulator of the stability and activity of multiple
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …

Pan-and isoform-specific inhibition of Hsp90: Design strategy and recent advances

J Yu, C Zhang, C Song - European Journal of Medicinal Chemistry, 2022 - Elsevier
In the past few decades, the development of heat shock protein 90 (Hsp90) inhibitors for
cancer treatment has not stopped. About twenty compounds have been evaluated in the …

Using natural product inhibitors to validate Hsp90 as a molecular target in cancer

L Neckers - Current topics in medicinal chemistry, 2006 - ingentaconnect.com
Heat shock protein 90 (Hsp90) is a molecular chaperone whose association is required for
stability and function of multiple mutated, chimeric, and over-expressed signaling proteins …

Natural heat shock protein 90 inhibitors in cancer and inflammation

TEMM Costa, NM Raghavendra, C Penido - European Journal of Medicinal …, 2020 - Elsevier
Heat shock protein (HSP) 90 is the most abundant HSPs, which are chaperone molecules
whose major roles are cell protection and maintenance by means of aiding the folding, the …

Heat shock protein (HSP) drug discovery and development: targeting heat shock proteins in disease

L Shrestha, A Bolaender, HJ Patel… - Current topics in …, 2016 - ingentaconnect.com
Heat shock proteins (HSPs) present as a double edged sword. While they play an important
role in maintaining protein homeostasis in a normal cell, cancer cells have evolved to co-opt …